Company: CRNX
Filing Date: 2025-06-26
Form Type: 8-K
Source: 0000950170-25-090405
Chunk: 3

Company: Crinetics Pharmaceuticals, Inc.
Filing Date: 2025-06-26
Form: 8-K
Item: Item 9.01
Chunk 3
---
Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

  Exhibit No.      Description                                                                  
 ────────────────────────────────────────────────────────────────────────────────────────────────
         99.1      Slide Presentation.                                                          
          104      Cover Page Interactive Data File (embedded within the Inline XBRL document)  

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

                                         Crinetics Pharmaceuticals, Inc.        
  Date:      June 26, 2025      By:      /s/ R. Scott Struthers, Ph. D.         
                                         R. Scott Struthers, Ph. D.